We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Latest Generation Immunoassay Analyzer to Be Displayed at AACC Annual Meeting

By LabMedica International staff writers
Posted on 02 Aug 2016
A large capacity, robust, yet simple-to-use chemiluminescence immunoassay analyzer will be presented at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. More...
(Shenzhen, China) will have the CL-1000i chemiluminescence immunoassay analyzer on display in Booth 2027 at the Philadelphia expo.

The CL-1000i is a robust yet simple-to-use chemiluminescence immunoassay analyzer. It offers a large capacity of 25 reagents, six sample racks, and supports non-stop replacement of reagents and consumables during testing. By integrating reliable chemiluminescence immunoassay technology with the latest in electrical and intuitive software improvements, CL-1000i reduces the complexity of laboratory operations and enhances diagnostic confidence. Currently Mindray offers 49 immunoassay tests for use with analyzer, with more to come in the near future.

Mindray has been a leading medical devices provider in the areas of patient monitoring and life support, in-vitro diagnostics, and medical imaging system for more than 25 years. In the in vitro diagnostics field, Mindray offers solutions for laboratories with different test volume requirements for hematology, biochemistry, chemiluminescence immunoassay, hemoglobin, flow cytometry, coagulation, and others.

Related Links:
AACC Annual Meeting & Clinical Lab Expo
Shenzhen Mindray Bio-Medical Electronics

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Unstirred Waterbath
HumAqua 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.